<p><em>Expert Perspectives</em>^{<em><i>®</i></em>} delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. <em>Expert Perspectives</em>^{<em><i>®</i></em>}<em> in HR+/HER2- Metastatic Breast Cancer</em> will feature community-selected experts and topics that we hope you will find of value in your clinical practice.</p> <hr /> <p><strong>VIEW THE TOPICS:</strong></p> <p> </p> <p><span style="color: #2f6a81;"><strong>Patient Care Perspectives</strong></span></p> <ul> <li>Preventing and Managing Osteoporosis in Patients With Metastatic Breast Cancer</li> <li>The Potential Role of Artificial Intelligence in Patient Education for Metastatic Breast Cancer</li> </ul> <p><br></p> <p><span style="color: #2f6a81;"><strong>Clinical Topic Updates</strong></span></p> <ul> <li>Recent Data With CDK4/6 Inhibitors for Metastatic HR+ HER2- Breast Cancer</li> <li>Treating Patients With ESR1-Mutated Metastatic HR+ HER2- Breast Cancer</li> </ul> <p><br></p> <p><span style="color: #2f6a81;"><strong>Expert Roundtables</strong></span></p> <ul> <li>Expert Roundtable Podcast: Treating Patients With HR+ HER2- Metastatic Breast Cancer Eligible for Multiple Targeted Therapies</li> <li>Later-Line Treatment for Metastatic HR+ HER2– Breast Cancer</li> </ul>